Home/Pipeline/ML2404

ML2404

Maternal Depression, Major Depression

PreclinicalActive

Key Facts

Indication
Maternal Depression, Major Depression
Phase
Preclinical
Status
Active
Company

About Medilabo

Medilabo develops intranasal drug delivery technology to treat neurodegenerative diseases by directly targeting the brain via the olfactory nerve.

View full company profile

Therapeutic Areas